Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 153687-35-5 | MDL No. : | MFCD22201150 |
Formula : | C12H12N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HHSVPEKERHITDE-UHFFFAOYSA-N |
M.W : | 216.24 | Pubchem ID : | 15221332 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 11 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 59.86 |
TPSA : | 44.12 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.72 cm/s |
Log Po/w (iLOGP) : | 1.94 |
Log Po/w (XLOGP3) : | 1.26 |
Log Po/w (WLOGP) : | 1.75 |
Log Po/w (MLOGP) : | 0.79 |
Log Po/w (SILICOS-IT) : | 1.99 |
Consensus Log Po/w : | 1.55 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.22 |
Solubility : | 1.31 mg/ml ; 0.00604 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.79 |
Solubility : | 3.55 mg/ml ; 0.0164 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.42 |
Solubility : | 0.0832 mg/ml ; 0.000385 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.71 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
35% | With trichlorophosphate In DMF (N,N-dimethyl-formamide) at 20 - 95℃; for 16 h; | 1H-PYRAZOLE-4-CARBALDEHYDE (55). To a solution of 1- (4-METHOXY-BENZYL)-1H- pyrazole (0.21 mol) (Synth. Commun. 1990, 20/18 ; 2849) in dry DMF (235 ml) was added POCL3 (1.5 eq. ) dropwise at room temperature. The mixture was then heated at 95°C for 16 hrs. After cooling to room temperature, the reaction mixture was neutralized by adding ice and saturated sodium carbonate solution. EtOAc (800 ml) was added and the organic layer was separated and washed several times with water. After drying (Na2SO4), the solvent was removed and the crude product was purified over silica gel to give 16.4 g (35percent yield) desired aldehyde 1-(4-METHOXY-BENZYL)-LH- pyrazole-4-carbaldehyde. It was heated with 150 ml TFA for 2 hrs. TFA was evaporated and the basified crude product was purified on silica gel to give 5.3 g of 55. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93.3% | With potassium carbonate In acetonitrile for 1 h; Reflux | To a mixture of 1H-pyrazole-4-carbaldehyde (100 mg, 1.04 mmol) and 1- (chloromethyl)-4-methoxybenzene (162 mg, 1.04 mmol) in CH3CN (6 mL) was added potassium carbonate (287 mg, 2.08 mmol), the resulting mixture was stirred at reflux for 1 h. The mixture was poured into water (20 mL) and extracted with EtOAc (3×20 mL). The organic layer was dried over Na2SO4and concentrated to give 1-(4-methoxybenzyl)- 1H-pyrazole-4-carbaldehyde (220 mg, 93.3 percent) as a colorless oil |
[ 1105039-93-7 ]
1-(4-Methoxybenzyl)-1H-pyrazole-4-carboxylic acid
Similarity: 0.94
[ 63874-95-3 ]
1-Benzyl-1H-pyrazole-4-carbaldehyde
Similarity: 0.82
[ 3528-45-8 ]
1-(4-Methoxybenzyl)-1H-pyrazol-5-amine
Similarity: 0.77
[ 98700-53-9 ]
1,5-Diphenyl-1H-pyrazole-4-carboxylic acid
Similarity: 0.74
[ 300657-03-8 ]
2-((2'-(5-Ethyl-3,4-diphenyl-1H-pyrazol-1-yl)-[1,1'-biphenyl]-3-yl)oxy)acetic acid
Similarity: 0.72
[ 63874-95-3 ]
1-Benzyl-1H-pyrazole-4-carbaldehyde
Similarity: 0.82
[ 936637-97-7 ]
Methyl 5-formylpyrazolo[1,5-a]pyridine-3-carboxylate
Similarity: 0.68
[ 1207839-91-5 ]
6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbaldehyde
Similarity: 0.68
[ 473249-36-4 ]
1-Propyl-1H-pyrazole-4-carbaldehyde
Similarity: 0.67
[ 1082066-00-9 ]
1-Cyclopropyl-1H-pyrazole-4-carbaldehyde
Similarity: 0.66
[ 1105039-93-7 ]
1-(4-Methoxybenzyl)-1H-pyrazole-4-carboxylic acid
Similarity: 0.94
[ 3528-45-8 ]
1-(4-Methoxybenzyl)-1H-pyrazol-5-amine
Similarity: 0.77
[ 99446-32-9 ]
5-Methoxypyrazolo[1,5-a]pyridine-3-carboxylic acid
Similarity: 0.76
[ 300657-03-8 ]
2-((2'-(5-Ethyl-3,4-diphenyl-1H-pyrazol-1-yl)-[1,1'-biphenyl]-3-yl)oxy)acetic acid
Similarity: 0.72
[ 1378695-64-7 ]
4-Methoxypyrazolo[1,5-a]pyridine-3-carboxylic acid
Similarity: 0.72
[ 1105039-93-7 ]
1-(4-Methoxybenzyl)-1H-pyrazole-4-carboxylic acid
Similarity: 0.94
[ 63874-95-3 ]
1-Benzyl-1H-pyrazole-4-carbaldehyde
Similarity: 0.82
[ 3528-45-8 ]
1-(4-Methoxybenzyl)-1H-pyrazol-5-amine
Similarity: 0.77
[ 98700-53-9 ]
1,5-Diphenyl-1H-pyrazole-4-carboxylic acid
Similarity: 0.74
[ 300657-03-8 ]
2-((2'-(5-Ethyl-3,4-diphenyl-1H-pyrazol-1-yl)-[1,1'-biphenyl]-3-yl)oxy)acetic acid
Similarity: 0.72